Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

MNCs Need Perseverance as China Ratchets Up Cost Containment amid Economic Woes Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on strategic thinking and vision on the Chinese pharmaceutic... (4/1/2019) Rare Diseases in China, Their High Treatment Costs, and the People Publicizing Patients' Plight (4/18/2019) Pharmaceutical Antitrust in China (4/17/2019) Bayer Pharma Hit with China-attributed Malware (4/16/2019) 'Reverse Patent Trolls' Plague Big Pharma in China (4/16/2019) FDA'S Pazdur Encourages Chinese Companies To Bring Low-Cost PD-1 Drugs To U.S. Market (4/3/2019) PharmExec: Use of External Innovation in China (4/3/2019) MNCs Need Perseverance as China Ratchets Up Cost Containment amid Economic Woes (4/1/2019) 3 Key Takeaways From BeiGene's CEO (3/26/2019) Why China's New Legal Framework Will Be A Magnet for Global Pharmaceuticals (3/21/2019) MAH Program A Shot in the Arm for Chinese Pharmaceutical Industry (3/19/2019) 5 Key Elements of Chinese Biopharma's "Cambrian Explosion" (3/17/2019) A Merck Cancer Treatment Has a Big Opportunity in China, Analyst Says (3/13/2019) China Sends Mixed Signals for Healthcare as Outlook Shift from Cautious Optimism to Cautious Pessimism for Many (3/1/2019) New IFPMA Code of Practice Tightens Restrictions on Gifts (with Case on RDPAC Code Changes) (2/27/2019) Chinese Biotech Feels Chill in Harsh Winter for Venture Capital (2/26/2019) Amendment of Drug Administration Law and...  (4/22/2019) China to Amend Healthcare Laws Relating ...  (4/22/2019) NMPA Solicits Comments on Draft Announce...  (4/19/2019) Recent Executive Moves  (4/19/2019) I-Mab Signs Agreement with Roche for Cli...  (4/18/2019) HitGen Achieves Milestone from DEL Disco...  (4/18/2019) U.S. Senators Propose Bill to Sanction C...  (4/18/2019) Lonza's Specialty API Business Disrupted...  (4/18/2019) Rexahn Pharma, BioSense Global Announce ...  (4/17/2019) CASI In-Licenses Exclusive Worldwide Rig...  (4/17/2019) GSK CEO Pledges to Learn from Mistakes i...  (4/17/2019) NMPA Issues the Chinese Edition of ICH G...  (4/17/2019) NHSA Issues the Action Plan for 2019 Nat...  (4/17/2019) NHC Pledges More Efforts to Address Medi...  (4/17/2019) I-Mab Bio and WuXi Bio Announce Long-ter...  (4/16/2019) IQVIA: Global Pharma to Grow Slower in the Next Five Yea... Pfizer and GSK Announce JV to Create a Global Consumer H... Top 25 Global Pharmaceutical Companies by Market Cap 201... CANbridge Receives IND Approval to Commence CAN008 Phase... Global Contract Pharmaceutical Manufacturing Market to R... Chinese Import of Medicine and Health Products Down in 2018 Due... Nicholas Hall Reports 8% Growth of OTC Gastrointestinal Market ... Nicholas Hall's Review of China's OTC Drug Market Performance 2... Review and Outlook of China's Foreign Trade of Medicines and He... Chinese Diabetes Drug Market Continues to be Dominated by MNCs ... China to Amend Healthcare Laws Relating to Physicians HitGen Achieves Milestone from DEL Discovery Alliance with M... Rexahn Pharma, BioSense Global Announce License Agreement fo... CASI In-Licenses Exclusive Worldwide Rights to Novel Anti-CD... GSK CEO Pledges to Learn from Mistakes in the Booming Chines... NMPA Solicits Comments on Draft Announcement for Nature ... NMPA Issues the Chinese Edition of ICH Guideline M4 Docu... CDE Seeks Comments on Draft ICH Guideline M10 CDE Publicizes Six More Drug Applications To Be Granted ... China Plans to Issue A New Set of Standards for Stem Cel... Amendment of Drug Administration Law and Draft Vaccine Manag... China Said to be Back-paddling on Pharma IP Stances as High-... USTR's 2018 Report for China's WTO Compliance Highlight IP I... Report: China Tightens IP Protection and Expands Patent Refo... China Claims Steady Progress in Key Indicators of IP in 2018... U.S. Senators Propose Bill to Sanction Chinese Pharmchem... Lonza's Specialty API Business Disrupted by Chinese Plan... Huahai Pharma Involved In Another Blood Pressure Drug Re... Novo Nordisk Pharmatech A/S signs Asia Pacific distribut... Trade Bodies Warns API Supply Chain Disruptions from Chi... I-Mab Signs Agreement with Roche for Clinical Research o... MSK-CTONG Collaboration Will Accelerate US-China Clinica... CStone Gains Chinese IND Approval for Avapritinib Phase ... LSK BioPharma and Hengrui Medicine Announce FDA Clearanc... Novartis Submits New Drug Application for Gilenya (Fingo... NHSA Issues the Action Plan for 2019 National Reimbursem... NHC Pledges More Efforts to Address Medicine Shortage NHC Publishes Report on Status Quo of Chinese Antibiotic... Ant Financial Aims to Disrupt China’s Health Insurance ... NHSA Solicits Comments on Draft Rules for Use of Basic M... Recent Executive Moves Chairman of Sunflower Pharma Arrested for Murder Recent Executive Moves Recent Executive Moves Recent Executive Movements Upcoming Event: Pharma China Annual Forum 2019 (April 9,... Pharma China Annual Forum 2019 (April 9, Shanghai) Upcoming: Auction - Pharma Site Closure in XiAn, China (... Pharma China Annual Forum 2019 (April 9, Shanghai) Upcoming Event: 4th Asean Pharma Packaging Conference Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON to Hold Pharma China Ann...   WiCON Publishes the China Phar...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links